Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HIV Seropositivity: early-phase trial registry
1 of 5 indexed HIV Seropositivity trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
HIV Seropositivity: 5 US clinical trials tracked, 1 recruiting.
HIV Seropositivity is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is AIM ImmunoTech, running 1 of these trials.
Enrollment posture brief
Registry condition hiv-seropositivity
OPEN 1 | RECR 20% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
HIV Seropositivity lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HIV Seropositivity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HIV Seropositivity is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates HIV Seropositivity research.
AIM ImmunoTech accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical HIV Seropositivity enrolment sits around 120 participants.
Median target enrolment is 120 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
HIV Seropositivity research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
University of Chicago
NCT05723653
Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US
University of Connecticut
NCT04832477
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants
Johns Hopkins University
NCT00130819
Safer Conception Intervention for HIV-1 Serodiscordant Couples
University of Washington
NCT03030768
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
AIM ImmunoTech
NCT00035893
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on HIV Seropositivity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HIV Seropositivity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HIV Seropositivity page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 HIV Seropositivity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AIM ImmunoTech sponsors the most HIV Seropositivity trials on record, review their full trial history before evaluating a specific study. See AIM ImmunoTech's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HIV Seropositivity condition card totals 5 registered trials; most-linked intervention Case management and referred substance abuse treatment; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.